Alistair S. Irvine

559 total citations
7 papers, 320 citations indexed

About

Alistair S. Irvine is a scholar working on Genetics, Molecular Biology and Biotechnology. According to data from OpenAlex, Alistair S. Irvine has authored 7 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 2 papers in Biotechnology. Recurrent topics in Alistair S. Irvine's work include Virus-based gene therapy research (5 papers), Heat shock proteins research (2 papers) and Microbial Metabolites in Food Biotechnology (1 paper). Alistair S. Irvine is often cited by papers focused on Virus-based gene therapy research (5 papers), Heat shock proteins research (2 papers) and Microbial Metabolites in Food Biotechnology (1 paper). Alistair S. Irvine collaborates with scholars based in United Kingdom, Ireland and Netherlands. Alistair S. Irvine's co-authors include Andrew Mountain, John R. Guest, Robert Crombie, Michael Antoniou, David J. Simpson, Steven G. Williams, Mark Griffiths, Jeffrey Green, Michael J. Gasson and Peter Trinder and has published in prestigious journals such as Nucleic Acids Research, Nature Biotechnology and Microbiology.

In The Last Decade

Alistair S. Irvine

7 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alistair S. Irvine United Kingdom 7 253 146 77 39 34 7 320
Thomas J. Graddis United States 10 186 0.7× 76 0.5× 102 1.3× 68 1.7× 20 0.6× 13 364
Y M Chen United States 10 163 0.6× 65 0.4× 132 1.7× 50 1.3× 24 0.7× 13 351
Marion d.C. Molina United States 9 379 1.5× 87 0.6× 33 0.4× 19 0.5× 34 1.0× 10 472
Amardeep Khushoo India 8 305 1.2× 60 0.4× 28 0.4× 17 0.4× 79 2.3× 8 367
Emily F. Freed United States 14 577 2.3× 126 0.9× 29 0.4× 49 1.3× 31 0.9× 19 652
Martijn Cordes Netherlands 8 169 0.7× 64 0.4× 64 0.8× 60 1.5× 14 0.4× 13 295
Xinyuan Zhu China 10 281 1.1× 134 0.9× 58 0.8× 34 0.9× 26 0.8× 16 409
Shogo Ebisu Japan 10 306 1.2× 70 0.5× 18 0.2× 45 1.2× 61 1.8× 13 385
R. Fleer United States 7 258 1.0× 43 0.3× 27 0.4× 19 0.5× 39 1.1× 11 323

Countries citing papers authored by Alistair S. Irvine

Since Specialization
Citations

This map shows the geographic impact of Alistair S. Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair S. Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair S. Irvine more than expected).

Fields of papers citing papers by Alistair S. Irvine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair S. Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair S. Irvine. The network helps show where Alistair S. Irvine may publish in the future.

Co-authorship network of co-authors of Alistair S. Irvine

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair S. Irvine. A scholar is included among the top collaborators of Alistair S. Irvine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair S. Irvine. Alistair S. Irvine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Williams, Steven G., Mark Griffiths, David J. Simpson, et al.. (2005). CpG-island fragments from the HNRPA2B1/CBX3genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnology. 5(1). 17–17. 108 indexed citations
2.
3.
Pelech, Steven, Andrew Mountain, Alistair S. Irvine, et al.. (2005). Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity. Cancer Immunology Immunotherapy. 55(3). 347–354. 19 indexed citations
4.
Gawn, Jonathan M., Norman J. Maitland, Daniel H. Palmer, et al.. (2004). Optimization of a synthetic β-catenin-dependent promoter for tumor-specific cancer gene therapy. Molecular Therapy. 10(1). 150–161. 28 indexed citations
5.
Irvine, Alistair S., et al.. (2000). Efficient nonviral transfection of dendritic cells and their use for in vivo immunization. Nature Biotechnology. 18(12). 1273–1278. 77 indexed citations
6.
Green, Jeffrey, et al.. (1998). A novel regulatory switch mediated by the FNR-like protein of Lactobacillus casei. Microbiology. 144(3). 705–717. 54 indexed citations
7.
Irvine, Alistair S. & John R. Guest. (1993). Lactobacilluscasei contains a member of the CRP-FNR family. Nucleic Acids Research. 21(3). 753–753. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026